Representing 20% growth over the prior year.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TXG:
- 10x Genomics Announces Preliminary Fourth Quarter and Full Year 2023 Results
- 10x Genomics’ three platforms featured in published study on breast tumors
- 10x Genomics initiated with bullish view at Guggenheim, here’s why
- 10x Genomics initiated with bullish view at Guggenheim
- Wolfe starts 10x Genomics at Outperform, cites ‘scarcity value’ of profile